Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,237 public trials 1,175 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Recruiting

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

NCT06060613

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations
  • The Angeles Clinic and Research Institute (Melanoma) Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center (Melanoma/NSCLC) Los Angeles, California, United States
  • Stanford Cancer Institute (Melanoma/NSCLC) Stanford, California, United States
  • Orlando Health Cancer Institute (Melanoma/NSCLC) Orlando, Florida, United States
View Trial Details
Recruiting

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

NCT07397338

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC, +22 more
Locations
  • Eastern Connecticut Hematology and Oncology Associates Norwich, Connecticut, United States
  • Tennessee Oncology Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Dallas Irving, Texas, United States
View Trial Details
Recruiting

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

NCT07365319

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Southern Cancer Center, P.C. Daphne, Alabama, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • Rocky Mountain Cancer Centers, LLP Pueblo, Colorado, United States
  • NYU Langone Hospital Long Island Mineola, New York, United States
View Trial Details
Recruiting

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

NCT05652686

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +22 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
View all 15 locations
View Trial Details
Recruiting

Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC

NCT07405190

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions